chrisvoncsefalvay/vaers-outcomes huggingface dataset:
stomach ache after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   Reporter did not allow further contact
Painful at injection site lasting 8 hours and  unable to move left arm without aiding  with other arm.   Chills for a few hours and  Migraine headache lasting for more than  12  hours with symptoms that are not relieved by Tylenol  (500mg twice).
At 02:30 pm on 10/12/21 (20 hours after the injections), I began shaking uncontrollably. I developed nausea and sever light headedness. The paramedics called, and I was taken to the hospital and admitted for fever and low blood pressure.
I noticed a large lump, it started as a rush that was itchy and painful. I had some joint and muscle pain.  The lump is still there and painful.  I did have diarreha and fatigue.
This infant had a fever of 104.5 (Tmax) for 48 hours. Within a few hours after administration of vaccines and excessive fussiness. At 48 hours, exam is consistent with right otitis media.
sweating; fever; vomiting; body ache; head ache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), PYREXIA (fever), VOMITING (vomiting), MYALGIA (body ache) and HEADACHE (head ache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced HYPERHIDROSIS (sweating), PYREXIA (fever), VOMITING (vomiting), MYALGIA (body ache) and HEADACHE (head ache). At the time of the report, HYPERHIDROSIS (sweating), PYREXIA (fever), VOMITING (vomiting), MYALGIA (body ache) and HEADACHE (head ache) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
11-16-06 At about 1800, noted a scratchy throat & runny nose, shoulder aches,and general malaise, no fever, felt nauseated. 11-17-06 Cont. symptoms, noted nasal mucus very sticky and stringy. Increased nasal drainage and productive coughing with clear mucus. 11-20-06 Today feels improving.
Vaccine taken at 6:30 am. Soreness in left arm started around 8-8:30. Felt tired all day but after a nap around 11:30ish felt nauseous, ate to try and calm it but it got worse throughout the day especially at night around 9pm finally relaxed enough to fall asleep, woke up at 7am feeling more nauseous than yesterday with a bad headache located in the front of my head not throbbed but constant. Laying down just felt really sick so I called my doctor around 9:15am.
Around bedtime, started to feel muscle pain/body aches. Got up to go to bathroom in middle of night. Having difficulty holding self up, shaking, looked pale. Able to urinate. Got cramps thinking to have a bowel movement, tried that, but passed out and woke up on the floor. Did not hit head. Got up, washed hands, went back to sleep. About 5:30am, hanging onto counter. Stayed in bed until about 8:30am, able to sit up, feeling better, but not feeling optimal.
Pt came up to me stating c/o racing heart, no chest pain or tightness, no SOB. BP 110/80, 80, c/o dizziness, nausea since receiving flu shot at 8AM. States site of injection bruising. No redness, swelling or warmth noted. Stated felt OK prior to getting shot. Called 911 for transport to ED for evaluation after c/o of chest tightness at 920. Pt able to walk to ambulance.
Pt recvd 3 doses of Engerix-B & 5 mins p/3rd dose started to feel lightheaded, band h/a, nauseated, & dry mouth; sx progressed to joint pain, tunnel vision, & unable to concentrate until the present time; sx lasted approx 2 months;
Three weeks later, her inflammation was down at least 60%; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), on 15Apr2021 as dose 2, single (Lot number: EW0153) for covid-19 immunisation. The patient's relevant medical history included: "autoimmune disease" (unspecified if ongoing), notes: has a history of autoimmune diseases; "Hashimotos" (unspecified if ongoing); "mixed connective tissue disease" (unspecified if ongoing); "psoriasis on her ankle" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, Single, Lot: ER8733), administration date: 25Mar2021, for COVID-19 Immunization, reaction(s): "Three weeks later, her inflammation was down at least 60%". The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "Three weeks later, her inflammation was down at least 60%".  Additional information: Reported as, History of autoimmune diseases, including Hashimotos, mixed connective tissue disease, and the other one is like no big deal, its annoying, but no one sees it. Its just psoriasis on her ankle that she puts coconut oil on. It just kind of soothes it so it doesn't get itchy. With her autoimmune disease, when she has one of them attacks, tendons and ligaments, they get inflamed and she can't move.By the first week of June she felt amazing. She was able to do her life long dream of driving cross country and visiting glass museums. She thought the improvement was going to last only a couple days but she hasn't had to take pain meds. She didn't really measure it. She thought she was just having a couple good days like that, which happens. It wears off in 5 months and in 6 months its gone, then she does it all over again. She was not 100%, but if you can keep your pain level below a 4, its easier to deal with it than when its constantly at an 8, 9, or 10. She slept in her car at camp grounds. She can't set up a tent and if she got on the ground in a sleeping back someone would have to come pick her up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300204036 same patient/event, different dose;
Swelling under left armpit.  Believe swollen lymph node. Sore for about 3 days. Today is one week after vaccine, swelling is still present but no longer hurts.
Within a week of receiving vaccination, patient started to have fever of 102, headache and cough.
Puffy below injection, very hot, red, itchy 7 days post injections  (Also after 1st injection but not itchy) Arm sore at  injection site, achy, hypersensitivity of skin all over,  face(cheeks (R>L) red and swollen
The LPN drew up and administered 0.3 milliliters instead of 0.5 millilters.
2-3 days after vaccine, patient experienced eczema-type skin irritation on entire body and hair falling  out in clumps. Rash took 2-3 months to heal and hair is still very thin >1 year later. patient saw a doctor to help treat her condition but just now reported to the pharmacy. stated adverse event was not reported by previous provider.
Pt came in for 2nd dose of flu shot. Pt was supposed to receive .25 cc. Received .50cc instead
Pt stated that her arm was itchy and upon looking it was red and swollen. When pt presented to the pharmacy the majority of her bicept was red and swollen. She purchased some Benadryl to take and was going to keep an eye on any worsening symptoms or spreading of the inflamed area.
Patient got weak and felt awful following his Covid vaccine shot. He required an ambulance to be called and was taken to the hospital and was monitored.
Facial, ear, chest rash. Flushed. Throat felt "clogged".
Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients; Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients). On 20-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Here is the patient info for the temp excursion/beyond use date excursion I called about on1/21/22. There were 15 total patients) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
the patient developed extreme hand and joint pain; the patient developed extreme hand and joint pain; she had an itchy rash all over her upper body; elevated CRP; This is a spontaneous report from a contactable Pharmacist. This pharmacist reported for a female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# number unknown) on 18Dec2020 for COVID-19 immunization. Medical history and concomitant drug were not reported. HCP wants to know if a patient who presented an adverse reaction to the first dose of the vaccine could receive the second one. The patient received the vaccine on 18Dec2020, and 12 days later on 30Dec2020, the patient developed extreme hand and joint pain, the patient was required to get analgesic medication up and down her arm and shoulder, patient was unable to lift her arm or do any personal care for herself 24 to 48 hours, she had an itchy rash all over her upper body, elevated CRP and those symptoms revolved in around five days. Per attached documentation, patients with a known severe allergic reaction to the vaccine should not receive a second dose, referred to the physicians diagnosed. Outcome of the event itchy rash all over her upper body, elevated CRP was recovered, for other events was unknown.  Information about lot/batch number has been requested.
Consistant bleeding from shot location for hours now. Due date. Dec 15 2018 pregnacy history to date positive.
I had my shot on 11Oct2023. On 14Oct2023, I began to have intermittent pain in my hips, especially at night. Five days following the shot, the pain moved from my hips to my right leg.; It is difficult for me to move up and down from a chair or in and out of a car; I had my shot on 11Oct2023. On 14Oct2023, I began to have intermittent pain in my hips, especially at night. Five days following the shot, the pain moved from my hips to my right leg.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 11Oct2023 as dose 1, single (Lot number: HG4671) at the age of 76 years, in left arm for covid-19 immunisation; for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 11Oct2023 as dose number unknown, single (Batch/Lot number: unknown), in right arm for immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID. Vaccination history included: Covid-19 vaccine (Dose 1; Manufacture unknown.), for Covid-19 Immunization; Covid-19 vaccine (Dose 2; Manufacture unknown.), for Covid-19 Immunization; Covid-19 vaccine (Dose 3; Manufacture unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 4; Manufacture unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 5; Manufacture unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 6; Manufacture unknown), for Covid-19 Immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 14Oct2023 at 12:00, outcome "not recovered", PAIN IN EXTREMITY (non-serious) with onset 16Oct2023, outcome "not recovered" and all described as "I had my shot on 11Oct2023. On 14Oct2023, I began to have intermittent pain in my hips, especially at night. Five days following the shot, the pain moved from my hips to my right leg."; MOVEMENT DISORDER (non-serious) with onset 16Oct2023, outcome "not recovered", described as "It is difficult for me to move up and down from a chair or in and out of a car". Therapeutic measures were not taken as a result of arthralgia, pain in extremity, movement disorder. Additional information: The patient had the shot on 11Oct2023. On 14Oct2023, the patient began to have intermittent pain in hips, especially at night. Five days following the shot, the pain moved from hips to right leg. The pain felt like a sharp pinching sensation. It is difficult for the patient to move up and down from a chair or in and out of a car. As of today, Oct2023, the pain has moved to the hips again. The pain continues to be present in both sides of the hips. The patient has been taking Advil almost everyday for the last 9 days.   The information on the batch/lot number for bnt162b2 omi xbb.1.5  has been requested and will be submitted if and when received.
Next day after flu, pneumonia and tetanus shots I began getting sick and my arm was sore for a week, I went to MD and she said I had pneumonia.
Hives all over body that started within 24 hours post vaccine, provider advised epsom salt baths.
Vaccine #1: Red, swollen, hot, painful and itchy at injection site + axillary lymphedema/pain lasting 3 days; migraine headache on day 11; days 14-15 itchiness to scalp, face, and both arms Vaccine # 2 : same localized reaction as above + 2 days of fever (100.8 with Tylenol), chills, aches, nausea
HEADACHE; LOW GRADE FEVER; This spontaneous report received from a parent concerned an 18 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on AUG-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 18 years old. No concomitant medications were reported. On an unspecified date, the patient experienced headache, and low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache and low grade fever was not reported. This report was non-serious. This parent/child case is linked to 20220901617.
Patient received the Janssen vaccine on 5/13/21 so was fully vaccinated when they tested positive for COVID-19 on 9/19/21.
Some of the vaccine appeared to drip down the patient's arm from the vaccination site when the Vanishpoint needle was retracted with administration.  Per guidelines, the patient did then receive another full dose of the vaccine the same day.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 10:40 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 10:40 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the fridge on 19-Apr-2021, moved to clinic on 29-Apr-2021 and proposed beyond use date was 19-May-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On 27-Apr-2021, at 09:00 A.M., the temperature recorded was 35 degree Fahrenheit, that has been reached by the vial.  On 28-Apr-2021, at 09:00 A.M, the temperature recorded was 33 degree Fahrenheit, that has been reached by the vial.  On 28-Apr-2021, at 10:00 A.M., the temperature recorded was 33 degree Fahrenheit that has been reached by the vial.  Temperature recordings were taken using a traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Patient given Tdap. (RT-IM) Sanofi C2889AA Mar 27 2010
Employee (physician) states following flu shot she developed a stiff neck, left upper extremity muscular pain and headache.
Student states she developed a "stiff neck" 1 day after receiving varicella vaccine. No other symptoms experienced.
Fever of 103.1 F, chills, local inflammation and warmth at the site of injection. Cellulitis was discussed as a possible differential.
given a Janssen vaccine on 06/12/2021 and a Moderna vaccine on 07/10/2021. Contacted patient and said he feels good with no issues.
Presented to clinic on 14July06 with c/o four day hx of HA, cramps, chills. New onset nausea and vomiting. Temp initially was 104.4 rectally. Transferred to ER for evaluation. Diagnoses with inflammatory response to vaccination. Reported to medical staff that he had his smallpox vaccination on 10July06. Vaccination report indicates day of vaccination as 12July06. ER report notes that he was admitted to the medsurg unit as an outpatient. Actual duration of stay not known at this time.
No additional AE; Inbound call from nurse calling to report administration of ROTATEQ to a child that is 9 months old.  HCP declined to provide full patient demographics.  Confirmed that no symptomatic adverse events were reported.  Caller stated that the administered; This spontaneous report was received from a nurse refers to a 9-month-old patient of unknown gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported.      On an unknown date, the patient was vaccinated with the third dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) oral, lot number 1968386, expiration date 23-MAY-2024, 2 milliliter, for prophylaxis (product administered to patient of inappropriate age). No adverse event was reported.
Woke up approx 36 hours later to pain radiating from neck to shoulder that is tender to touch. Throughout day, lymph node left neck very swollen and tender to touch. Area visibly swollen, sensitive to movement. Palpable lymph node very tender, size of a nickel.
Pt. stated today she had rxn to immunization given on 11-28-16. Redness, swelling, itching, excessive soreness (aching) about 3-5 inches on and around injection site-left arm.
This spontaneous report was received from a health professional refers to a patient of unknown gender and age. Information regarding patient's medical history, concurrent condition, drug reactions/allergies and concomitant therapy were not provided. On 09-FEB-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # L026741, expiry date: 18-MAY-2017). The temperature excursion details were reported as follows: temperature 0.6 degree C, time frame 30 hours, 20 minutes. COMVAX and GARDASIL appeared on the product list since they were involved in the excursion, however no improperly stored doses of these vaccines were administered. No adverse effect was reported. This is one of the eight reports received from the same reporter. Additional information has been requested.
devel fever 6JUL, CBC > 40000 @ time of adm;
autonomic dysfunction.; Autoimmune Disease; injection site bump; numbness and tingling in her extremities and her face; numbness and tingling in her extremities and her face; menstrual cycle abnormalities; Abdominal pain; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a 17-years-old female patient. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On 07-NOV-2016, the patient was vaccinated with a first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (Lot #, expiration date, dose, route of administration and anatomical location of vaccine were not provided) for preventing cervical cancer.  On an unspecified date, subsequent to the patient vaccination, the patient developed a large bump at the injection site. She also began experiencing heart palpitations, numbness and tingling in her extremities and her face, abdominal pain, menstrual cycle abnormalities, nausea, and dizziness. Additionally, based upon her chronic and severe post-Gardasil symptoms, Plaintiff has been diagnosed with various medical conditions, including, but not limited to, autonomic dysfunction and has Resulted in Her Suffering from Severe, Debilitating, Disabling and Painful Chronic Injuries. At the reporting time, the outcome of the event was unknown.  The reporter considered the events of shingles to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL)  Upon internal review the event of Autoimmune Disease was considered as medically significant.
pt recv vax 20APR95 & approx 20-30mins following vax pt exp GI distress & vomited a small amount of pre-digested foods;pt exp h/a,gen body weakness & felt sweaty;pt stated that it was the first time had felt this way;dx vasovagal rxn